Based on the information provided, I cannot provide a personal account of whether Ozempic has reduced my desire for desserts. However, I can share some relevant information about Ozempic that may help answer your question.

Ozempic (generic name: semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist medication used to improve glycemic control in adults with type 2 diabetes. It is administered subcutaneously once a week. GLP-1 receptor agonists work by mimicking the functions of natural GLP-1 hormones in the body, which include stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying.

While Ozempic is primarily used for glycemic control, some studies suggest that GLP-1 receptor agonists may have additional effects on appetite regulation and weight loss. These medications may reduce appetite and promote weight loss by slowing gastric emptying, leading to a feeling of fullness and reduced food intake.

However, the available information does not specifically address whether Ozempic has reduced the desire for desserts. It is possible that some individuals taking Ozempic may experience a reduced appetite or altered food preferences, including a decreased desire for sweets. However, this may not be a universal experience, and individual responses to the medication may vary.

In summary, while Ozempic may have effects on appetite regulation and food preferences, there is no specific information available about its impact on the desire for desserts. Individual experiences with the medication may vary.

Sources:

1. <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/important-safety-information-ozempic-semaglutide-injection>
2. <https://www.ncbi.nlm.nih.gov/books/NBK537223/>
3. <https://www.drugpatentwatch.com/drugs/ozempic>